Rein Therapeutics logo

Rein Therapeutics

RNTX | NASDAQ
Chart Builder DCF Calculator
$0.40
-$0.15 (-27.55%)
At close: Nov 16, 2026, 4:00 PM ET
$0.38
-$0.02 (-5.35%)
After-hours: Nov 16, 2026, 7:30 PM ET
-27.55%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
36.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #621/1021 (Top 61%)

Key Statistics

Market Data

Market Cap $34.51M
1D Range
0.28 0.50
52W Range
0.28 1.88

Valuation (TTM)

PE -0.22
PB 3.38
EV/EBITDA 0.29

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $6.00
Loading financial charts...

Profile

Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The c...

Sector Healthcare
Industry Biotechnology
Employees 10
IPO Date Jun 29, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$6.00
Upside
+1400.00%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.